Loading...

Tumor-Specific Fluorescence-Guided Surgery for Pancreatic Cancer Using Panitumumab-IRDye800CW: A Phase I Dose-Escalation study

BACKGROUND: Complete surgical resection remains the primary curative option for pancreatic ductal adenocarcinoma (PDAC) with positive margins in 30%−70% of patients. The present study aimed to evaluate the use of intraoperative tumor-specific imaging to enhance surgeons’ ability to detect visually-o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Lancet Gastroenterol Hepatol
Main Authors: Lu, Guolan, van den Berg, Nynke S., Martin, Brock A., Nishio, Naoki, Hart, Zachary P., van Keulen, Stan, Fakurnejad, Shayan, Chirita, Stefania U., Raymundo, Roan C., Yi, Grace, Zhou, Quan, Fisher, George A., Rosenthal, Eben L, Poultsides, George A.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7367758/
https://ncbi.nlm.nih.gov/pubmed/32416764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(20)30088-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!